T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Badger Meter
BMI
$3.78B
| $11.8M | ﹤0.01% |
63,237
+468
| +0.7% | +$85.5K |
|
1077
Illumina
ILMN
$29.1B
| $11.8M | ﹤0.01% |
112,652
-111,695
| -50% | -$12.5M |
|
1078
Match Group
MTCH
$8.56B
| $11.7M | ﹤0.01% |
385,725
-407,606
| -51% | -$12.9M |
|
1079
TAL Education Group
TAL
$6.43B
| $11.6M | ﹤0.01% |
1,091,581
+265,728
| +32% | +$3.14M |
|
1080
Avantor
AVTR
$9.37B
| $11.6M | ﹤0.01% |
549,276
-1,250,471
| -69% | -$30.1M |
|
1081
Fox Class A
FOXA
$27.5B
| $11.6M | ﹤0.01% |
337,947
+2,465
| +0.7% | +$80.5K |
|
|
BBOT
1082
BridgeBio Oncology
BBOT
$740M
| $11.6M | ﹤0.01% |
1,130,677
| – | – |
|
1083
Lyell Immunopharma
LYEL
$337M
| $11.4M | ﹤0.01% |
393,618
+57,044
| +17% | +$2.72M |
|
1084
PennyMac Financial
PFSI
$4.13B
| $11.4M | ﹤0.01% |
120,067
+9,105
| +8% | +$824K |
|
1085
Reinsurance Group of America
RGA
$16.4B
| $11.3M | ﹤0.01% |
54,973
-88,205
| -62% | -$17.6M |
|
1086
Berkshire Hathaway Class A
BRK.A
$1.09T
| $11M | ﹤0.01% |
18
| – | – |
|
1087
Hasbro
HAS
$13.6B
| $11M | ﹤0.01% |
188,373
+7,250
| +4% | +$430K |
|
1088
Mueller Water Products
MWA
$3.98B
| $11M | ﹤0.01% |
614,826
-79,643
| -11% | -$1.37M |
|
1089
Pharvaris
PHVS
$2.38B
| $11M | ﹤0.01% |
585,271
-172,644
| -23% | -$3.51M |
|
1090
BorgWarner
BWA
$13.8B
| $10.9M | ﹤0.01% |
338,715
+10,143
| +3% | +$351K |
|
1091
Tenaya Therapeutics
TNYA
$164M
| $10.9M | ﹤0.01% |
3,513,724
+167,202
| +5% | +$690K |
|
|
SNV
1092
DELISTED
Synovus
SNV
| $10.9M | ﹤0.01% |
270,557
+39,701
| +17% | +$1.5M |
|
1093
Generac Holdings
GNRC
$12.8B
| $10.9M | ﹤0.01% |
82,111
+2,047
| +3% | +$283K |
|
1094
Petrobras Class A
PBR.A
$104B
| $10.8M | ﹤0.01% |
788,153
+179,000
| +29% | +$2.66M |
|
1095
Kaspi.kz JSC
KSPI
$18.9B
| $10.7M | ﹤0.01% |
82,960
+12,737
| +18% | +$1.56M |
|
1096
Solventum
SOLV
$14.7B
| $10.6M | ﹤0.01% |
200,064
+115,391
| +136% | +$7M |
|
1097
Janux Therapeutics
JANX
$978M
| $10.6M | ﹤0.01% |
252,358
+232,762
| +1,188% | +$10.9M |
|
1098
Dorian LPG
LPG
$1.95B
| $10.5M | ﹤0.01% |
249,311
+24,353
| +11% | +$1.05M |
|
1099
PBF Energy
PBF
$8.81B
| $10.5M | ﹤0.01% |
227,301
+37,839
| +20% | +$1.94M |
|
1100
Symbotic
SYM
$5.43B
| $10.2M | ﹤0.01% |
291,393
-78,253
| -21% | -$3.17M |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.